<DOC>
	<DOCNO>NCT00447005</DOCNO>
	<brief_summary>To evaluate clinically recommend dose AG-013736 ( Axitinib ) Japanese patient review safety AG-013736 ( Axitinib ) follow single multiple dosing .</brief_summary>
	<brief_title>Study Of AG-013736 ( Axitinib ) In Patients With Advanced Solid Tumors</brief_title>
	<detailed_description />
	<mesh_term>Axitinib</mesh_term>
	<criteria>Patients histologically cytologically diagnose advanced malignant solid tumor Patients standard therapy effective , suitable therapy Central lung lesion involve major blood vessel Patients treat bevacizumab VEGFR inhibitor ( )</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Safety</keyword>
	<keyword>PK</keyword>
	<keyword>Biomarker</keyword>
</DOC>